Kura Oncology
KURA
KURA
104 hedge funds and large institutions have $531M invested in Kura Oncology in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
+5
Holders Change %
+5.05%
% of All Funds
2.25%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
16
Increased
32
Reduced
28
Closed
11
Calls
$547K
Puts
$9K
Net Calls
+$538K
Net Calls Change
+$673K
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$14.1M |
| 2 |
Goldman Sachs
New York
|
+$10.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.86M |
| 4 |
FI
Fosun International
Hong Kong,
China
|
+$1.65M |
| 5 |
Man Group
London,
United Kingdom
|
+$1.61M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.29M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$4.65M |
| 4 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$4.15M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$2.38M |
